Theresa Matkovits
2018
In 2018, Theresa Matkovits earned a total compensation of $306.3K as Chief Development Officer at Matinas BioPharma Holdings.
Compensation breakdown
| Option Awards | $232,037 |
|---|---|
| Salary | $74,263 |
| Total | $306,300 |
Matkovits received $232K in option awards, accounting for 76% of the total pay in 2018.
Matkovits also received $74.3K in salary.
Rankings
In 2018, Theresa Matkovits' compensation ranked 13,118th out of 14,244 executives tracked by ExecPay. In other words, Matkovits earned more than 7.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,118 out of 14,244 | 8th |
Division Manufacturing | 5,314 out of 5,759 | 8th |
Major group Chemicals And Allied Products | 1,985 out of 2,122 | 7th |
Industry group Drugs | 1,703 out of 1,811 | 6th |
Industry Pharmaceutical Preparations | 1,300 out of 1,385 | 6th |
Source: SEC filing on October 1, 2020.
Matkovits' colleagues
We found four more compensation records of executives who worked with Theresa Matkovits at Matinas BioPharma Holdings in 2018.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019